Certolizumab pegol Completed Phase 1 Trials for Healthy Volunteers Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT02365948A Study of Certolizumab Pegol to Evaluate Pharmacokinetics and Safety in Adult Healthy Chinese Subjects
NCT00845663Comparison Bioequivalence Study: Pre-filled Syringe (Reference) Versus Auto-injection Device (Test)